Send feedback

A2ML1 p.Cys970Tyr

c.2909G>A · rs1558526 · VCV384673

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely pathogenic
0.6729 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 27.3%, mid) — too common for a highly-penetrant pathogenic allele
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense0.6729likely pathogenic
REVEL0.637indeterminate
SaProtLLR -7.25tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.6GERP 0.94, phastCons 1
Regional constrainto/e 0.94unconstrained · MANE · 52 kb · p 0.02 · regional, not allelic
Overall
CADD23.9PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 27.3% Middle Eastern · 1,426/5,228 alleles
Filtering AF 26.1% ClinGen BA1/BS1 input FAF95, joint · FAF99 25.6%
Overall 22.7% 366,375/1,612,900 alleles · common
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 40.2% 2
Middle Easterngrpmax 27.3% 4
European (non-Finnish) 25.6% 4
Remaining individualsnot grpmax-eligible 22.5% 4
Amishnot grpmax-eligible 17.5% 6
Finnishnot grpmax-eligible 16% 6
Admixed American 15.3% 7
South Asian 15.3% 7
African / African-American 4.33% 23
East Asian 0.0624% 1,603

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
A2ML1
Protein
p.Cys970Tyr
Coding
c.2909G>A
MANE Select
NM_144670
dbSNP
rs1558526
Type
single nucleotide variant
Location
chr12:8857224 (GRCh38)
Gene constraint
LOEUF 0.953 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 80.61 · 5 PDB
Residue 970
a disulfide bond; a cross-link site; a UniProt-annotated variant site (risk factor for otitis media); a UniProt-annotated variant site (in)
Full A2ML1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/a2ml1-p-cys970tyr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown